(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.03%.
Adicet Bio's earnings in 2026 is -$115,014,000.On average, 9 Wall Street analysts forecast ACET's earnings for 2026 to be -$115,887,083, with the lowest ACET earnings forecast at -$159,201,901, and the highest ACET earnings forecast at -$83,979,271. On average, 8 Wall Street analysts forecast ACET's earnings for 2027 to be -$104,695,594, with the lowest ACET earnings forecast at -$169,715,234, and the highest ACET earnings forecast at -$53,203,634.
In 2028, ACET is forecast to generate -$2,686,762 in earnings, with the lowest earnings forecast at -$6,758,571 and the highest earnings forecast at $9,252,806.